TerminatedNot Applicable

Wolff-Parkinson-White Syndrome Anterograde Refractory Period of Accessory Duct

France13 participantsStarted 2009-02

Plain-language summary

The study consists of the realization of a new esophageal stimulation for patients already stimulated 10 years ago. The investigators would like to make a long term evaluation of the evolution of anterograde effective refractory period of accessory duct in the WPW syndrome. This study will be realized by esophageal stimulation.

Who can participate

Age range21 Years – 64 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 21 \< age \< 64 years * First esophagal stimulation with evaluation of effective anterograde refractory period \> 10 years * Informed consent signed * Diagnosis of Wolff-Parkinson-White syndrome * No procedure of ablation of accessory duct Exclusion Criteria: * Ablation of accessory duct * Patient with contraindication to esophageal stimulation * Patient with contraindication to effort test

What they're measuring

Measurement of effective anterograde refractory period of accessory duct and its evolution for a follow up superior to 10 years

Timeframe: Day 0

Trial details

NCT IDNCT00873470

SponsorNantes University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2012-12

View on ClinicalTrials.gov More Wolff-Parkinson-White Syndrome trials